Replimune Group, Inc. (NASDAQ:REPL) Receives $19.43 Consensus PT from Analysts
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) has earned an average rating of “Buy” from the nine analysts that are presently covering the company, Marketbeat reports. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price […]
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) has earned an average rating of “Buy” from the nine analysts that are presently covering the company, Marketbeat reports. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price […]
